Business Description
Marvel Biosciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA57384M1077
Description
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -13.46 | |||||
| Debt-to-Equity | -0.56 | |||||
| Debt-to-EBITDA | -2.36 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 13.6 | |||||
| 3-Year FCF Growth Rate | 27 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.68 | |||||
| 9-Day RSI | 22.78 | |||||
| 14-Day RSI | 28.25 | |||||
| 6-1 Month Momentum % | 22.58 | |||||
| 12-1 Month Momentum % | 50.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.05 | |||||
| Days Payable | 6121.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.2 | |||||
| Shareholder Yield % | -8.87 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -318.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -12.09 | |||||
| EV-to-EBITDA | -12.09 | |||||
| EV-to-FCF | -7.28 | |||||
| Earnings Yield (Greenblatt) % | -8.27 | |||||
| FCF Yield % | -16.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MBCOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Marvel Biosciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.028 | ||
| Beta | 0 | ||
| Volatility % | 73.64 | ||
| 14-Day RSI | 28.25 | ||
| 14-Day ATR ($) | 0.010235 | ||
| 20-Day SMA ($) | 0.101275 | ||
| 12-1 Month Momentum % | 50.94 | ||
| 52-Week Range ($) | 0.0365 - 0.14 | ||
| Shares Outstanding (Mil) | 44.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Marvel Biosciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Marvel Biosciences Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Marvel Biosciences Corp Frequently Asked Questions
What is Marvel Biosciences Corp(MBCOF)'s stock price today?
The current price of MBCOF is $0.07. The 52 week high of MBCOF is $0.14 and 52 week low is $0.04.
When is next earnings date of Marvel Biosciences Corp(MBCOF)?
The next earnings date of Marvel Biosciences Corp(MBCOF) is .
Does Marvel Biosciences Corp(MBCOF) pay dividends? If so, how much?
Marvel Biosciences Corp(MBCOF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers